Xenon Pharmaceuticals Inc (XENE)
Cost of Revenue
$77.67M
TTM · Period ending: · USD
XENE Cost of Revenue
Latest reported$77.67Mperiod ending
Latest reported$77.67Mperiod ending
XENE Cost of Revenue ($0.00 → $77.67M)
Annual cost of revenue
High-resolution chart · PNG
XENE cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 2,543,000 | |
| 2,560,000 | |
| 167,512,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 6,000,000 | |
| 25,573,000 | |
| 1,114,000 | |
| 2,762,000 | |
| 5,903,000 | |
| 6,210,000 | |
| 7,320,000 | |
| 0 |